# FDA Inspection 1220079 - Shandong Xinhua Pharmaceutical Co., Ltd. - September 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-co-ltd/45190bd3-3fe9-4971-9e6e-e1ad3e6cec44
Source feed: FDA_Inspections

> FDA Inspection 1220079 for Shandong Xinhua Pharmaceutical Co., Ltd. on September 15, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220079
- Company Name: Shandong Xinhua Pharmaceutical Co., Ltd.
- Inspection Date: 2023-09-15
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1220079 - 2023-09-15](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-co-ltd/aade3719-3ae4-447b-899c-7443064b9d71)
- [FDA Inspection 1000050 - 2016-03-31](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-co-ltd/1ee5fd4b-2a70-4c1f-9092-2326019df1de)
- [FDA Inspection 875678 - 2014-04-04](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-co-ltd/2fd1e3d6-d8dc-45d8-b7ef-ae358ff52ca7)
- [FDA Inspection 875678 - 2014-04-04](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-co-ltd/3f7b2d02-cfb1-4167-b8e9-7433e16f181a)
- [FDA Inspection 685447 - 2010-07-13](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-co-ltd/349563fa-630c-48a9-944d-8e44b8fc2ca6)

Company: https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-co-ltd/acea3619-5739-4a9f-a4b2-82e0207194b3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c